GLP-1 Weight Loss and Skin Laxity: What the 2026 Data Shows About Prevalence and Procedural Options

GLP-1 receptor agonists have changed weight management for millions of patients, and with that shift has come a well-documented side effect: visible changes in skin quality, volume, and elasticity, informally dubbed “Ozempic face.” For most of the past few years, evidence on this phenomenon was largely anecdotal — clinician observation and social media commentary rather than data. That changed in 2026, when two independent US survey studies, one covering 504 patients and another covering 1,226, put real numbers behind what dermatologists were already seeing in practice. Here's what the research actually shows, and where fractional laser fits into the evidence-based treatment picture.

How Common Is GLP-1-Associated Skin Laxity?

The smaller of the two 2026 studies found that 38.7% of GLP-1 users reported some cutaneous change, with facial volume loss (10.9%), sagging (8.3%), and jowling (7.7%) as the most frequently cited concerns. Onset was often fast: 55.1% of affected patients noticed changes within the first five months of starting treatment, with risk concentrated in patients over age 55 and those losing more than 20 pounds.

The larger 1,226-patient survey found a similar pattern at a higher rate, with skin sagging reported by 37.7% of respondents overall (arms were the most affected area, at 71% of those reporting sagging), facial volume loss in 29.2%, and worsened skin quality in 24.1%. The key finding across both studies is dose-dependence: concerns scaled directly with how much weight was lost. In the larger study, 90.9% of patients who lost more than 20% of body weight reported an aesthetic concern, compared to just 50.5% of those who lost less than 10%.

Why Rapid Fat Loss Affects Skin This Way

The mechanism is straightforward physiology. Subcutaneous fat acts as a structural scaffold under the skin. When that volume disappears quickly, the skin's collagen and elastin network — which gives skin its ability to retract and conform to a smaller underlying frame — often can't keep pace, particularly in patients whose skin already has reduced elasticity from age or prior sun exposure. The faster and larger the weight loss, the less time the dermal matrix has to remodel, which is consistent with why age and total weight lost were the two strongest predictors identified in the survey data.

What the Research Says About Treatment

Neither study evaluated a single intervention in isolation, but both point clinicians toward the same categories of evidence-based options, depending on what's driving the concern:

• For skin sagging: radiofrequency, high-intensity focused ultrasound (HIFU), fractional lasers, and RF microneedling — all aimed at stimulating collagen and elastin synthesis with minimal downtime.

• For facial volume loss: dermal fillers and biostimulatory injectables (poly-L-lactic acid, calcium hydroxylapatite), with early initiation flagged as potentially preventing further progression.

• For diminished skin quality/texture: retinoids, antioxidants, microneedling, radiofrequency, and laser resurfacing.

• For muscle tone loss: resistance training paired with electromagnetic muscle stimulation.

Where CO2 Laser Resurfacing Fits — and Where It Doesn't

Fractional laser resurfacing, including ablative CO2, is named directly in the research as a legitimate collagen-stimulating option for GLP-1-related skin quality and mild-to-moderate facial or neck laxity. That tracks with how CO2 resurfacing works generally: controlled micro-injury to the dermis triggers a remodeling response that rebuilds collagen and elastin over the following weeks.

It's worth being precise about scope, though. The larger study found arms were the single most affected area for sagging — a region ablative facial laser doesn't treat. And for patients with more significant volume loss or laxity, the literature points toward HIFU, RF microneedling, or injectable biostimulators, none of which Cor.e Laser Studio offers. IPL, the other modality we provide, is well-suited to the tone and pigmentation irregularities that often accompany post-weight-loss skin, but it isn't a laxity treatment. Matching the right tool to the actual concern matters more than defaulting to whatever's available.

Common questions

Is “Ozempic face” inevitable if I'm on a GLP-1 medication? No. Even in the higher-prevalence study, well under half of patients reported visible skin changes, and risk was concentrated in those losing larger amounts of weight quickly and in patients over 55.

Can CO2 laser resurfacing fix loose skin from GLP-1 weight loss? It can meaningfully improve mild-to-moderate facial and neck laxity and skin quality by stimulating collagen remodeling. It is not the right tool for significant sagging or for areas like the arms, which the data show are most affected — those cases are typically better served by RF, HIFU, or a plastic surgery consult.

How soon does skin laxity show up after starting a GLP-1? In one 2026 survey, just over half of affected patients noticed changes within the first five months of treatment.

Should I wait until I've finished losing weight before getting laser treatment? Generally, yes. Resurfacing works best once weight has stabilized, since continued fat loss can undercut the results. A consultation can help determine the right timing for your situation.

If GLP-1-related changes in facial texture, tone, or mild-to-moderate skin laxity are a concern for you, Cor.e Laser Studio offers free consultations to talk through whether CO2 laser resurfacing or IPL is an appropriate fit — and an honest referral elsewhere if it isn't.